ClinicalTrialsFeeds.org

NIH Clinical Trials Results via RSS

Evaluation of RTVue in Corneal Measurement

Dates, Status, Enrollment

Brief Summary

Skip to Participation Criteria

Official Title: "Evaluation of RTVue in Corneal Measurement"

The purpose of this study is to evaluate RTVue measurement of the cornea in various ocular conditions to include normal, pathology, post refractive surgery and cataract.

  • Study Type: Observational
  • Study Design: Observational Model: Cohort, Time Perspective: Prospective
  • Study Primary Completion Date: December 2010

Arms, Groups and Cohorts in this Clinical Trial

  • Normal cornea
  • Post laser refractive surgery
  • Cornea pathology
  • Cataract surgery

Criteria for Participation in this Clinical Trial

Inclusion Criteria

Normal cornea:

  • 18 years of age or older
  • No corneal pathology
  • No prior ocular surgery and no prior laser refractive surgery

Post laser refractive surgery:

  • 18 years of age or older
  • No corneal pathology
  • No prior ocular surgery except laser refractive surgery
  • At least 1 week post laser refractive surgery without complication

Corneal pathology:

  • 18 years of age or older
  • Clinical diagnosis of one or more type of corneal pathologies, including corneal scar and keratoconus, etc., excluding eyes in which corneal power measurement are not clinically relevant (e.g., eyes requiring corneal transplant)
  • No prior laser refractive surgery

Cataract surgery:

  • 18 years of age or older
  • No corneal pathology
  • No prior ocular surgery, no prior laser refractive surgery, and no prior cataract surgery
  • Post surgery visit shall only include eyes without complication

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: 18 Years

Maximum Age for this Clinical Trial: N/A

Are Healthy Volunteers Accepted for this Clinical Trial: Accepts Healthy Volunteers

Clinical Trial Investigator Information

  • Lead Sponsor
    • Optovue
  • Provider of Information About this Clinical Study
    • Qienyuan Zhou, PhD, Optovue